NIG
PFE icon

NFJ Investment Group’s Pfizer PFE Stock Holding History

NFJ Investment Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,398,757
Closed -$39.3M – 248
2026
Q1 		$39.3M Sell
1,398,757
-783,593
-36% -$20.9M 1.49% 17
2025
Q4 		$54.3M Sell
2,182,350
-151,364
-6% -$3.82M 1.96% 9
2025
Q3 		$59.5M Sell
2,333,714
-18,911
-0.8% -$467K 2.04% 6
2025
Q2 		$57M Buy
2,352,625
+746,651
+46% +$17.4M 1.99% 9
2025
Q1 		$40.7M Buy
1,605,974
+817,137
+104% +$21.4M 1.37% 17
2024
Q4 		$20.9M Buy
788,837
+404,266
+105% +$11M 0.67% 53
2024
Q3 		$11.1M Buy
384,571
+43,719
+13% +$1.28M 0.33% 89
2024
Q2 		$9.54M Hold
340,852
– – 0.29% 102
2024
Q1 		$9.46M Hold
340,852
– – 0.26% 106
2023
Q4 		$9.81M Buy
+340,852
New +$10.3M 0.27% 100

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NFJ Investment Group's PFE Position: Q2 2026 in Review

NFJ Investment Group sold out of Pfizer (PFE) in Q2 2026, closing a stake of 1,398,757 shares — an estimated $39.3M sold.

NFJ Investment Group first reported a position in PFE in Q4 2023 and held it in 10 quarters. The position peaked at $59.5M in Q3 2025. 2,828 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • NFJ Investment Group reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • NFJ Investment Group sold 1,398,757 Pfizer shares in Q2 2026, an estimated $39.3M.
  • NFJ Investment Group first reported a position in Pfizer in Q4 2023 and held it in 10 quarters.
  • NFJ Investment Group's Pfizer position peaked at $59.5M in Q3 2025.
  • 2,828 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on NFJ Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.